Publications

Invited Lectures and Workshops

  1. Spectrum of Orbital Inflammatory Disorders. CyberSight, Orbis International. New York, NY. July 17, 2020. 
  2. Acute physician needs in public health emergencies. Canadian Ophthalmology Society Annual Meeting 2020, June 26. 
  3. Lumps and bumps for general ophthalmologist. PHC Winter Clinical Day, Feb 22, 2020. 
  4. 2019 American Academy of Ophthalmology Annual Meeting. Oct 12-15, 2019. San Francisco, USA. 
    • Conceptual Approach: Orbital lymphoproliferative disease 
    • Radiology of orbital tumors 
    • Case: Optic nerve sheath meningioma 
    • Case: Recurrent lacrimal gland adenoid cystic carcinoma 
    • Gender and Blindness: Initiative to produce equity
  5. Current Status: Targeted therapy for locally advanced periocular malignancies. CyberSight, Orbis International, New York. July 17, 2019. 
  6. Nepal Ophthalmic Society Annual Conference 2019, Sept 27-28, 2019. Lumbini, Nepal a. Tips on creating an aesthetic reconstruction with Hughes Flap after cancer resection b. Leadership and Gender 
  7. 7th Annual COECSA Congress, Aug 21-23, 2019. Kigali, Rwanda. 
    • Toxicity of cancer treatment for ophthalmologist 
    • Pediatric orbital tumors 
    • Update on targeted therapy for locally advanced periocular and orbital malignancies
    • Tips on aesthetic cancer reconstruction 
  8. Invited Lecturer. Rwanda International Institute of Ophthalmology, Aug 20, 2019.
    • Approach to management of orbital mass 
    • Oculoplastic & orbit basics 
  9. Global Ophthalmology Beyond Vision 2020. Grand Rounds, UBC Department of Ophthalmology & Visual Sciences, May 24, 2019. 
  10. 2nd Annual Meeting, North American Society of Academic Orbital Surgeons. April 4-9, 2019, Orlando, FL. 
    • Panelist, Advances in Targeted Therapy 
    • Mutational Landscape of Conjunctival Melanoma 
  11. The 34th Asia-Pacific Academy of Ophthalmology Congress, Bangkok, Thailand. March 6-9, 2019 
    • Recent advances in targeted therapy for periocular malignancies 
    • Lentigo malign with spread to conjunctival MIS. 
  12. Evidence-based management of lacrimal gland tumors. CyberSight, Orbis International, New York. Feb 1, 2019. 
  13. Combined reconstruction of face and lid: An oculoplastic surgeon’s perspective. 5th Biennial Orbital Oncology and Oculofacial Plastic Surgery Symposium. UT MD Anderson Cancer Center, Houston, TX. Jan 25-26, 2019. 
  14. Course Faculty and Moderator. Contemporary management of complex skin cancers. Memorial Sloan Kettering Cancer Center, New York, NY. Nov 2-3, 2018. 
    • Periocular malignancies: special considerations. 
    • Techniques for eyelid reconstructions. 
  15. Orbital Tumor Course. AAO 2018, Skills Transfer Course. Chicago, IL, October 15-18, 2016. 
  16. Recognition and management of cosmetic filler complications. Annual Congress of the European Society of Ophthalmic Plastic and Reconstructive Surgery. Bucharest, Romania, Sept 13-15, 2018. 
  17. Invited Speaker. XXXVIII National and International Congress of the Sociedad Columbiana de Oftalmologia. Cartagena de Indias, Colombia. July 25-28, 2018. 
    • Current update and controversies of hedgehog pathway blockage 
    • Addressing complex orbital vascular malformation with multidisciplinary approach
    • Evidence for best management of lacrimal gland tumors 
    • Periocular side effects from targeted therapy and cancer management
    • Working with complex facial flaps after cancer resection 
  18. Visiting Speaker. Combined University of Missouri Columbia-Kansas City Symposium. April 20-21, 2018. Columbia, MO. 
    • Toxicity of cancer treatment for the general ophthalmologist 
    • What is the current landscape of global ophthalmology?
  19. Keynote Speaker. British Oculoplastic Surgery Society Annual Meeting. London, England, June 21-23, 2017. 
    • Non-surgical Management of Periocular and Orbital Malignancies. 
    • Multidisciplinary Management of Orbital Vascular Tumors. 
    • Global Ophthalmology for Oculoplastic Surgeons 
  20. Targeted therapy and sentinel lymph node biopsy for periocular malignancy. Mayo Clinic Department of Ophthalmology Grand Rounds. May 2, 2017. 
  21. Combined approach with Onyx embolization for posterior vascular malformation of the orbit. PanAmerican Oculoplastic Society Meeting 2017. April 20-22, 2017. 
  22. Ptosis repair: Techniques and tips. Grand Rounds, Lumbini Eye Institute, Nepal. April 2, 2017. 
  23. Investigation for an orbit presentation: You can manage the orbit too! UBC/BCSEPS Clinical Day. Vancouver, BC, Feb 25, 2017. 
  24. Orbital Oncology and Oncologic Oculofacial Plastic Surgery: A Multidisciplinary Approach. UT MD Anderson Cancer Center. Jan 20-21, 2017 
    • Combined reconstruction of face and lid: An oculoplastic surgeon’s perspective
    • Surgical management of eyelid and periocular melanoma 
    • WHO Global Action Plan: How to contribute in a meaningful way 
  25. Orbital Tumor Course: Secondary and Metastatic Orbital Tumors. AAO 2016, Skills Transfer Course. Chicago, IL, October 15-18, 2016. 
  26. Periocular Rejuvenation: An Oculoplastic Surgeon’s Perspective. Canadian Society of Aesthetic Specialty Nurses, Aesthetic Symposium, Vancouver, BC. September 16-17, 2016.
  27. Sentinel Lymph Node Biopsy for Periocular Malignancies. Asian-Pacific Association of Ophthalmology Annual Congress. Taipei, Taiwan. March 24-27, 2016. 
  28. World Ophthalmology Congress 2016. Guadalajara, Mexico. Feb 5-9, 2016. 
    • Multi-modal Management of Thyroid Eye Disease: Role of Surgery, Radiation and Biologics 
    • Orbital and Ocular Adnexal Manifestation of Cancer and Cancer Treatment 
  29. Key Ophthalmic Procedures. UBC Ophthalmology Update: Knowledge and Skills Seminar for Emergency Physicians. Nov 21, 2015. 
  30. Anatomy Dissection Lab: TORIC Course. University of Toronto, Toronto, Canada. May 25-27, 2015. 
  31. Course Faculty, Advances in Orbital Oncology and Oculofacial Plastic Surgery Course, UT MD Anderson Cancer Center. Feb 2015. 
    • Combine Reconstruction of Eyelid and Face: Unique considerations in cancer patient.
    • Surgical Treatment of Melanoma 
    • Global Ophthalmology 
  32. Not All Drooping are Created Equal. Grand Rounds Aravind Eye Care System. October 2014. 
  33. Lumps and Bumps: How to be the hero. Ophthalmology Update: Knowledge and Skills Seminar for Family Physicians. University of British Columbia, Sept 27, 2014. 
  34. Biologics for Periocular Malignancies. University of British Columbia/BCSEP, May 9th, 2014. 
  35. Skill Transfer Lab: Fat Transfer Techniques. American Academy of Ophthalmology Annual Meeting, Instruction Course. New Orleans, Nov 16-19, 2013. 
  36. Fat Transfer: The Natural Rejuvenation. European Society of Ophthalmic Plastic Reconstructive Surgery Annual Conference. Barcelona, Sept 19-21, 2013. 
  37. Course Faculty, Advances in Orbital Oncology and Oculofacial Plastic Surgery Course, UT MD Anderson Cancer Center. Feb 2012.
    • Surgical Treatment of Eyelid and Periocular Disease 
    • Eyelid Reconstruction: Unique Consideration in Cancer Patients 
  38. Phacodynamics for the New Phaco Surgeon. Bacolod Negros, Philippines. Feb 2011. 
  39. Emergency referral policy to the eye clinic and its impact to wait-time and patient satisfaction. Toronto Western Hospital Emergency Department. 2009 
  40. Common Eye Complaints for Family Physicians. Women’s College Hospital Family Medicine Resident Half Day. 2009.

Invited Publications & Book Chapters

  1. Yin VT and Cherwek DH. An overview of global health for healthcare professional. Global Health and Volunteering – A Guide for Healthcare Professionals. Springer 2018. (In press) 2. Francis J and Yin VT. Eyelids and orbit. Jatin Shah’s Head and neck surgery and oncology, 5th Ed. Elsevier 2018. (In press) 
  2. Yin VT and Esmaeli B. Eyelid Melanoma. American Academy of Ophthalmology, OPS Knowledge Base. 
  3. Yin VT and Esmaeli B. Systemic assessment of patients with ocular and adnexal malignancies. American Academy of Ophthalmology, Focal Points Module 2016. 5. Yin VT, Merritt H, Esmaeli B. Eyelid and ocular surface carcinoma: Diagnosis and management. Clin Dermatol 2015;33(2):159-69. PMID:25704936 
  4. Yin VT, Chou E, Nakra T. Lower Lid and Midface Rejuvenation: Multi-discipline apporach. Oculoplastics: The transeyelid midface lift. Clin Plast Surg 2015;42(1):95-101. PMID:2544076
  5. Yin VT, Merritt H, Esmaeli B. Targeting EGFR and Sonic Hedge Hog Pathways for Locally Advanced Eyelid and Periocular Carcinomas. World J Clin Cases. 2014; 2:432-8. PMID:25232546 
  6. Yin V, Esmaeli B. Eyelid tumors: Sentinel Lymph Node Assessment and Biopsy for Eyelid and Conjunctival Malignancies. In: Clinical Ophthalmic Oncology – Eyelid and Conjunctival Tumours. 2nd. Ed(s) Pe’er J Singh AD. Springer 111-124, 2014. 
  7. Yin V, Zaidi A. (CD associate eds.) In: 2007 Toronto Notes. Greenwald A. and Heng M. (eds.) Toronto Notes Medical Publishing Incorporated: Toronto. 

Peer-Reviewed Publications

  1. Morin J, Rasmussen S, Yin VT. Diffuse large B-cell lymphoma mimicking subperiosteal orbital abscess. Ophthalmic Plastic Reconstr Surg (In submission) 
  2. Teja S, Mann C, Hooper P, Buys Y, Yin VT. The Canadian Ophthalmology Society’s adaptation of the medically necessary time sensitive surgical procedures triage and prioritization tool. Can J Surgery (In Press) 
  3. Yin VT, Barker CA, Francis J, Jaben K. Ocular anterior segment ischemia from internal eye shield during radiotherapy. (In Press) 
  4. Daigle P, Leung V, Yin V, Kalin-Hajdu E, Nijhawan N. Personal protective equipment (PPE) during the COVID-19 pandemic for oculofacial plastic and orbital surgery. Orbit. DOI:10.1080/01676830.2020.1781200 
  5. Hussain A, Tucker N, DeAngelis DD, Yin VT, Ing E, Arthurs B, Gill HS, Hardy I, Hurwitz J, Kratky V, Maleki B, Nijhawan N, Oestreicher J, Zafar A. Guidelines for vismodegib in the management of periocular basal cell caricoma. Can J Ophthalmol 2019 Dec 31 [Epub ahead of print] PMID: 31901307 
  6. Adulkar N, Cheng C, Lee L, Rasmussen S, Yin VT. Permeability of optic nerve by high concentration of hyaluronidase for management of hyaluronic acid facial filler emoblism. Plastic Reconstr Surg 2019 Jul; 144(1):43e-48e. PMID: 31246809 
  7. Francis JH, Barker CA, Yin VT, Carvajal RD, Chapman P, Abramson DH, Gobin YP. Chemoreduction of orbital recurrence of uveal melanoma by intraarterial melphalan. Ocular Oncol Pathol 2019 Apr; 5(3):186-189. PMID: 31049326 
  8. Oded S, Bell D, Su S, Wester ST, Jiang K, Yin VT, Shinder R, Hayek B, Kim HJ, Tetzlaff MT, Esmaeli B. Pathological features and clinical course in patients with recurrent or malignant orbital solitary fibrous tumor/hemangiopericytoma. Ophthalmic Plastic Reconstr Surg (In Press)
  9. Mori S, Navarrete-Dechent C, Petukhova TA, Lee EH, Rossi AM, Posthof MA, Dunn LA, Roman BR, Yin VT, Coit DG, Hollman TJ, Busam KJ, Nehal KS, Barker CA. Tumor board conferences for multidisciplinary skin cancer management: A survey of US cancer centers. JNCCN (In Press)
  10. Liu RT, Henkleman E, Popescu O, Yin VT. Nodular fasciitis: A rapidly enlarging destructive periorbital mass in an infant. Am J Ophthalmic Case Reports 2018 Apr 19 https://doi.org/10.1016/j.ajoc.2018.04.019
  11. Chen LYC, Qi R, Park S, Irvine R, sideman M, Kelsall JT, Collins D, Yin VT, Slack G, Mattman A, Carruthers MN. Utility of serum IgG4 levels in a multiethnic population. Am J Med Sci 2018;355(1):61-66. PMID: 29289265
  12. Prada S, Deshmukh A, Shretha PG, Basnet P, Kandel RP, Lewelland S, Bassett K, Yin VT. Prevalence of blindness and cataract surgery coverage in Narayani zone, Nepal – A Rapid Assessment of Avoidable Blindness (RAAB) study. Br J Ophthalmol 2018;102(3):291-294. Epub 2017 Oct 21 PMID: 29055904
  13. Zhang Z, Ho S, Varas G, Rajak S, Yin VT, Dolman PJ, McNab A, Heathcote JG, Valenzuela AA. Multi-centered international review of orbital exenteration and reconstruction in oculoplastic and orbit practice. Br J Ophthalmol. 2018;102(5):654-8. [Epub ahead of print] 2017 Aug 26 PMID: 28844052
  14. Yin VT, Esmaeli B. Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma. Curr Pharm Des 2017;23:655-659. PMID: 27928965
  15. Liu RT, Goold L, White VA, Rasmussen S, Yin VT. A case of Actinomyces dacryocystitis mimicking malignancy. Canadian J Ophthalmol. 2016;51(5):e147-e149.
    http://dx.doi.org/10.1016/j.jcjo.2016.06.016
  16. Esmaeli B, Yin VT, Hanna EY, Kies MS, William WN, Bell D, Frank SJ. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck 2016;38(8):1258-62. PMID:27027275
  17. Baker MS, Yin VT, Ivan D, Allen RC, Carter KD, Esmaeli B, Shriver EM. Epidemiology and prognosis of primary periocular sweat gland carcinoma. Ophthal Plast Reconstr Surg. 2016 Mar 11 [Epub ahead of print] PMID:26974419
  18. Tetzlaff M, Curry J, Yin V, Pattanaprichakul P, Manonukul J, Uiprasertkul M, Manyam G, Wani K, Aldape K, Zhang L, Prieto V, Esmaeli B. Distinct pathways in the pathogenesis of sebaceous carcinoma implicated by differentially express microRNAs. JAMA Ophthalmol. 2015; 133(10):1009-16. [Online First July 23, 2015.] doi:10.1001/jamaophthalmol.2015.2310
  19. Ozgur OK, Yin V, Chou E, Ball S, Kies M, William WN, Migden M, Thuro BA, Esmaeli B. Hedgehog pathway inhibition for locally advanced periocular basal cell carcinoma and basal cell nevus syndrome. Am J Ophthalmol 2015 Apr 30 [Epub ahead of print] PMID:25935097
  20. Merritt H, Yin VT, Esmaeli B. Treatment Challenges with Benign Bony Tumors of the Orbit. Ocular Oncology Path 2015;1:111-120. PMID
  21. Yin VT, Warneke C, Merritt H, Esmaeli B. Number of excisions required to obtain clear surgical margins and prognostic value of AJCC T category for patients with eyelid melanoma. Br J Ophthalmol 2014;98(12):1681-5. [Epub 2014 Jul 22]. PMID:25053759.
  22. Yin VT, Sniegowski M, Esmaeli B. Indications and limitations of vismodegib for basal cell carcinoma. JAMA Ophthalmol 2014;132(7):905-6. PMID:25010179.
  23. Sagili S, Yin V, Esmaeli B, O’Donnell B, Eckstein R, Malhotra R. Squamous cell carcinoma of the caruncle. Ophthal Plast Reconstr Surg 2014 May 8 [Epub ahead of print]. PMID:24814271.
  24. Sniegowski M, Roberts D, Bakhoum M, Yin VT, Esmaeli B. Ocular Adnexal Lymphoma: Validation of American Joint Commitee on Cancer 7th Edition Staging Guidelines. British J Ophthalmol. 2014:98:1255-60. PMID:24759874.
  25. Nasser QJ, Roth KG, Warneke, CL, Yin VT, El Sawy T, Esmaeli B. Impact of AJCC “T” designation on risk of regional lymph node meatastasis in patient with squamous cell carcinoma of the eyelid. British J Ophthalmol. 2014;98:498-501. PMID:24429279.
  26. El-Sawy T, Bakhoum MF, Tetzlaff M, Nasser QJ, Prieto VG, Ivan D, Sniegowski M, Yin VT, Pan C, Durairaj V, Esmaeli B. Primary orbital melanoma in association with cellular blue nevus. Digital J Ophthalmol 2014 July 14. DOI:10.5693/djo.01.2014.02.001.
  27. Sniegowski M, Yin V, Esmaeli B. RE: “American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcome.” Letter. Ophthal Plast Reconstr Surg. 2013; 29(4):326. PMID: 23839639.
  28. Yin VT, Wiraska TA, Esmaeli B. Cutaneous eyelid neoplasm as toxicity of vemurafenib therapy. Ophthal Plast Recontr Surg. 2015;31(4):e112-5. [Epub ahead of print, 2014 May 14]. PMID:24833447.
  29. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Recontr Surg 2013; 29(2):87-92. PMID: 23446297.
  30. Pfeiffer ML, Yin VT, Esmaeli B. Regional recurrence of sebaceous carcinoma of the caruncle after eleven years. JAMA Ophthalmol. 2013;131(8):1091-2. [Epub ahead of print] 2013 Jun 13:1-2 doi: 10.1001/jamaophthalmol.2013.321. PMID: 23765335
  31. Pfeiffer ML, Yin VT, Bell D, Esmaeli B. Sclerosing polycystic adenosis of the lacrimal gland. Ophthalmol. 2013;120(4):873-873.e1. PMID: 23552085.
  32. Yin VT, Weisbrod D, Eng K, Schwartz C, Kohly R, Mandelcorn E, Lam WC, Daneman N, Simor A, Kertes P. Antibiotic resistance of ocular flora after repeated use of topical antibiotics post intravitreal injection. Ophthalmol. 2013 Apr; 131(4):456-61. PMID: 23430175.
  33. Yin VT, Nijhawan N, Oestricher J. Post-traumatic lacrimal-antral fistula: Demonstrated by CT-DCG. Ophthal Plast Reconstr Surg (In submission)
  34. Hayes JS, Yin VT, Piyathaisere D, Weiland JD, Humayun MS, Dagnelie G. Visually guided performance of simple tasks using simulated prosthetic visions. Artif Organs 2003; 27(11):1016-28 PMID:14616520
  35. Kelley AJ, Yang L, Hess D, Yin V, Dagnelie G. Comparison of presentation modes for reading and face recognition in simulated prosthetic vision. [Abstract] Journal of Vision 2003; 3(12): 58a
  36. Dagnelie G, Yin V, Hess D, Yang L. Phosphene mapping strategies for cortical visual prosthesis recipients. [Abstract] Journal of Vision 2003; 3(9): 222a

Abstracts

  1. Yin VT. Efficacy and challenges of hedgehog inhibition for LaBCC prior to surgery. 2019 Canadian Ophthalmology Society Annual Meeting. Jun 13-16, 2019. Quebec City, Quebec.
  2. Yin VT, Qiao G, Rossman D, Dolman P. Comparing the effect of levator advancement and conjunctival-mullerectomy ptosis surgery on tear production and dry eye symptoms. APAO 2017, Singapore, March 1-5, 2017. 
  3. Yin VT, Heran M. Combined approach with Onyx embolization for posterior vascular malformation of the orbit. APAO 2017, Singapore, March 1-5, 2017. 
  4. Valenzuela AA, Zhang Z, Yin V, Dolman PJ, McNaab A. Multi-centered international review of orbital exenteration and reconstruction methods with outcomes. APAO 2017, Singapore, March 1-5, 2017. 
  5. Yin VT, Kandel RP, Pradhan S, Shrestha PG, Yadav M, Basnet P, Bassett K. Cataract barriers and outcome in Narayani zone, Nepal – A Rapid Assessment of Avoidable Blindness (RAAB) Study. International Society of Geographical & Epidemiological Ophthalmology Congress, Durban, South Africa. October 31st and November 1st, 2016. 
  6. Yin VT, Dolman P. A Simplified Frontalis Sling Technique for Congenital Ptosis. World Ophthalmology Congress 2016. Guadalajara, Mexico. Feb 5-9, 2016. 
  7. Goold L, Qiao G, Rossman D, Dolman P, Sniegowski M, Yin VT. Comparing the effect of levator advancement and conjunctival-mullerectomy on tear production and dry eye symptoms. ASOPRS 46th Fall Scientific Symposium, Las Vegas, USA. Nov 12-13, 2015. 
  8. Yin VT, Esmaeli B. Frequency of repeated orbital imaging in patients with orbital and ocular adnexal tumor. Canadian Ophthalmology Society Annual Meeting, Victoria, BC. June 18-20, 2015. 
  9. Yin VT, Rasmussen S, Anderson D, Brown E. Basomelanocytic tumor in a patient with Gorlin Syndrome. Canadian Ophthalmology Society Annual Meeting, Victoria, BC. June 18- 20, 2015.
  10. Esmaeli B, Yin VT, Chou E, William W, Kies M, Migden M. Targeting the hedgehog pathway in patients with periorbital locally advanced basal cell carcinoma or basal cell nevus syndrome. ASOPRS 45th Fall Scientific Symposium, Chicago, USA. Oct 16-17, 2014.
  11. Baker M, Yin VT, Ivan D, Esmaeli B, Shriver E. Primary periocular sweat-gland carcinomas: Epidemiology and prognosis. ASOPRS 45th Fall Scientific Symposium, Chicago, USA. Oct 16-17, 2014.
  12. Esmaeli B, Yin VT, Hanna E, Kies M, William W, Bell D, Frank S. Globe sparing surgery and post-operative high dose radiation therapy for lacrimal gland carcinoma. ASOPRS 45th Fall Scientific Symposium, Chicago, USA. Oct 16-17, 2014.
  13. Yin VT, Tetzlaff MT, Curry J, Wani K, Manyam GC, Bell D, Zhang L, Aldape K, Esmaeli B. Differential expression of microRNAs in sebaceous carcinoma of eyelid compared with sebaceous adenoma. ASOPRS 45th Fall Scientific Symposium, Chicago, USA. Oct 16-17, 2014.
  14. Yin VT, Baker M, Ivan D, Shriver E, Esmaeli B. Epidemiology and prognosis of primary perocular sweat -gland carcinomas. ESOPRS 33rd Annual Meeting, Budapest, Hungary. Sept 11-13, 2014. #CO3:3
  15. Yin VT, Stanciu N, Shore J, Nakra T. Patient satisfaction with full face rejuvenation using fat grafting. ASOPRS 44th Annual Fall Scientific Symposium, New Orleans, LA. Nov 14-15, 2013.
  16. Yin VT, Sniegowski M, Wernecke C, Esmaeli B. Margin Control and Delayed Reconstruction After Surgical Resection in Patients with Melanoma of Eyelid, Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery Meeting Program, New Orleans, LA, 11/2013.
  17. Sniegowski M, Roberts D, Yin VT, Esmaeli B. Ocular Adnexal Lymphoma: Validation of American Joint Committee on Cancer 7th Edition Staging Guidelines. American Society of Ophthalmic Plastic & Reconstructive Surgery Meeting Program, New Orleans, LA, 11/2013.
  18. Yin VT, Wiraszka TA, Sniegowski M, Esmaeli B. Periocular Neoplasms as a Side Effect of Systemic Anti-BRAF Therapy, Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery Meeting Program, New Orleans, LA, 11/2013.
  19. Sniegowski M, Wernecke C, Morrison W, Yin VT, Esmaeli B. Prognostic Factors for Metastasis Merkel Cell Carcinoma of the Eyelid. American Society of Ophthalmic Plastic & Reconstructive Surgery Meeting Program, New Orleans, LA, 11/2013.
  20. Yin VT, Esmaeli B. Margin control and delayed reconstruction after surgical resection in patients with melanoma of eyelid.
    32nd ESOPRS Annual Meeting, Barcelona, Spain. Sept 19-21, 2013. (Ref No 236) Congreso Panamericano: Oculoplastica sin Fronteras, Cancun, Mexico. Oct 12-14, 2014.
  21. Yin VT, Esmaeli B. Periocular neoplasm as a side effect of systemic anti-BRAF therapy. 32nd ESOPRS Annual Meeting, Barcelona, Spain. Sept 19-21, 2013. (Ref No 234)
  22. Yin VT and Esmaeli B. Development of squamous carcinoma of eyelid while on BRAF inhibitors for metastatic melanoma. Summer Symposium, Women in Ophthalmology, Snowmass, CO. Aug 1-4, 2013.
  23. Shore JW, Yin V, Stanciu N, Nakra T, Blaydon SM. Strategies for proving ocular surface protection in the setting of acute and chronic facial nerve palsy. 12th International Facial Nerve Symposium, Boston, MA. 
  24. Yin V, Weisbrod D, Eng K, Mandelcorn E, Kohly R, Schwartz C, Lam WC, Simor A, Kertes P. The effect of repeated topical fluoroquinolone use post intravitreal injection for neovascular Age-related Macular Degeneration (AMD) on ocular surface flora.
    (ID #143) Canadian Ophthalmology Society 2012 Annual Meeting, Toronto, Canada. (ID #PA061) American Academy of Ophthalmology 2012 Annual Meeting, Chicago, IL.
  25. Yin V, Wright T, Devenyi R, Eng K, Kertes P, Westall C and Lam WC. Comparison of triamcinolone acetonide-assisted cortical vitreous removal vs. ICG-assisted ILM peeling for the repair of idiopathic macular hole: An interim report. 4th Congress of the Asian-Pacific Vitreo-Retina Society, Nov 2009, Taipei.
  26. Yin V and Yan D. Optic disc size affects the utility of central corneal thickness as a risk factor for glaucoma. University of Toronto Department of Ophthalmology and Vision Science Research Day, 2009
  27. Armogan N, Yin V and Ali F. C3F8 gas injection in the treatment of significant hemorrhage secondary to branch retinal vein occlusion. (BRVO). American Society of Retinal Specialist 23rd Annual Meeting, Montreal, 2005
  28. Yin V, Ali F, Armogan N. Management of significant intraretinal hemorrhage in patients with BRVO using C3F8 pneumatic displacement. Annual Ophthalmology Departmental Research Day, University of Toronto, 2005